Analysts have provided the following ratings for Selecta Biosciences (NASDAQ:SELB) within the last quarter:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 5 | 0 | 0 | 0 | 0 |
Last 30D | 2 | 0 | 0 | 0 | 0 |
1M Ago | 2 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
According to 5 analyst offering 12-month price targets in the last 3 months, Selecta Biosciences has an average price target of $5.6 with a high of $9.00 and a low of $4.00.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased